| • Aamna Abbasi (BA 2019) is a PhD candidate at Duke University in the Department of Integrative Immunobiology. |
• Anna Albisetti (Postdoc 2019) is a senior scientific collaborator at Swiss Tropical and Public Health Institute in Basel, Switzerland. |
| • Jessica Bonnar (BA 2019) is a graduate student researcher at MIT studying molecular assembly and ER quality control of collagen in the Department of Biology, Shoulders Lab. |
• Yoshio Boris (BA 2019) is an associate director of business development at Resolian, a Bioanalytical Clinical Research Organization. |
| • Philippe de Gaiffier (BA 2018) is an associate strategy officer for the Bill & Melinda Gates Foundation. |
• Ramy El-Diwany, MD, PhD (BA 2008) finished his general surgery residency and started a fellowship in transplant surgery at Johns Hopkins in Baltimore, Maryland. |
| • Alexandre Fernandes (Postdoc 2013) is the development director of IIED Europe, responsible for establishing the organization as a new voice in the European Union on issues of climate, sustainability, and justice. |
• Adam Freund (PhD 2010) is the founder and CEO of Arda Therapeutics, a biotechnology company focused on treatment of chronic diseases and aging by depleting pathogenic cells. |
| • Sophia Friesen (PhD 2023) is a science communications manager at the University of Utah Health. | • Patty Garcia Leon (PhD 2012) was recently promoted to senior clinical scientist at Genentech. |
| • Jim Graziano, PhD (BA 1998) is the vice president of operations for InduPro, a biotechnology company in Seattle, WA. |
• Jennifer Hall (BA 2021) is a first-year medical student at Duke University School of Medicine and is hoping to go into surgical oncology or neuro-oncology. |
| • Kanika Khanna (Postdoc 2023) is a scientific program leader at Gladstone Institutes of Virology. |
• Daniel Kramer (PhD 2020) is the engagement manager at ClearView Healthcare Partners, a global-strategy consulting firm serving the life-science sector. |
| • Tina Liu (Postdoc 2021) is an assistant professor of molecular biology & biochemistry at Rutgers University-New Brunswick, where her lab explores the diverse biology of CRISPR-Cas systems and engineers them for nucleic acid sensing and diagnostics. |
• Muskan Sheth (BA 2023) is a research associate in cell engineering at Ascend Gene & Cell Therapies, where she focuses on optimizing the adeno-associated virus (AAV) as a vector for gene and cell therapeutics by developing cell lines and high-throughput screening assays. |
| • Katie Sieverman (PhD 2017) is the director of content at Codon Learning, where she builds college STEM courseware that supports evidence-based teaching practices and helps students learn how to learn. | • Kersh Thevasundaram (PhD 2020) is head of science at Clairity Technology, where he leads the development of natural, low-cost CO2 adsorbents for direct air capture. |
| • Darmood “David” Wei PhD (BA 2008) is a senior toxicologist for the US Food and Drug Administration. | • Oliver Zill (PhD 2020) is the founder & principal of init.bio, a company that helps biotech startups with R&D management, scientific strategy, and computational platforms for drug discovery through its unique fractional operator model. |
MCB Transcript welcomes stories from our alumni. Click here to let us know what you've been up to!
Back to Main Fall 2023 Newsletter Page
| Connect With Us! | ||||
 MCB X (formally Twitter) |
 LinkedIn Postdocs, PhDs, or Undergrads |
 Cal Alumni Network |
 Give to MCB |
|
